|
| 37052343 | Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study. | | 2023 |
| 35527425 | Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people â¿¥65â¿¿years of age. | HIV Medicine | 2023 |
| 35233903 | Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium. | HIV Medicine | 2022 |
| 35466963 | High efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/I. | AIDS | 2022 |
| 34555326 | Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium. | Lancet HIV | 2021 |
| 33686573 | Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged⿿⿥⿿65 Years: Week 48 Results of a Phase 3b, Open-Label Trial. | Infectious Diseases and Therapy | 2021 |
| 33382756 | Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium. | PLoS ONE | 2020 |
| 32649866 | Allogeneic bone marrow transplantation with post-transplant cyclophosphamide for patients with HIV and haematological malignancies: a feasibility study. | Lancet HIV | 2020 |
| 31634860 | The Ryan White HIV/AIDS Program after the Patient Protection and Affordable Care Act full implementation: a critical review of predictions, evidence, and future directions. | Topics in antiviral medicine | 2019 |
| 29683855 | A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients. | AIDS | 2018 |
| 28933204 | Healthcare utilization and direct costs of non-infectious comorbidities in HIV-infected patients in the USA. | Current Medical Research and Opinion | 2018 |
| 29306043 | Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis. | Clin Gastroenterol Hepatol | 2018 |
| 29293156 | HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052. | Journal of acquired immune deficiency syndromes (1999) | 2018 |
| 29152781 | Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure. | Hepatology | 2018 |
| 28208122 | A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care. | Top Antivir Med | 2017 |
| 28867497 | Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial. | Lancet | 2017 |
| 28385131 | Virologic outcomes in early antiretroviral treatment: HPTN 052. | | 2017 |
| 28384058 | Analysis of HIV Integrase Resistance in Black Men Who Have Sex with Men in the United States. | AIDS Res Hum Retroviruses | 2017 |
| 28546090 | Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial. | Lancet HIV | 2017 |
| 28938040 | Human Immunodeficiency Virus Medicine. | Journal of Infectious Diseases | 2017 |
| 29253205 | Comorbidities Among US Patients With Prevalent HIV Infection-A Trend Analysis. | Journal of Infectious Diseases | 2017 |
| 28272164 | Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults. | Journal of acquired immune deficiency syndromes (1999) | 2017 |
| 27753684 | A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults. | J Acquir Immune Defic Syndr | 2017 |
| 28196003 | Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults. | Journal of acquired immune deficiency syndromes (1999) | 2017 |
| 27977411 | Dolutegravir monotherapy: when should clinical practice be clinical research? | Antivir Ther | 2017 |
| 27774892 | Atazanavir Plus Cobicistat: Week 48 and Week 144 Subgroup Analyses of a Phase 3, Randomized, Double-Blind, Active-Controlled Trial. | Current HIV Research | 2017 |
| 26859828 | Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial. | Journal of acquired immune deficiency syndromes (1999) | 2016 |
| 27424812 | Antiretroviral Therapy for the Prevention of HIV-1 Transmission. | N Engl J Med | 2016 |
| 27171740 | Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B-Coinfected Adults. | Journal of acquired immune deficiency syndromes (1999) | 2016 |
| 27404187 | Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel. | JAMA | 2016 |
| 27036991 | Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, activ | Lancet HIV,The | 2016 |
| 27491245 | DEAR DOCTOR... WHAT ABOUT CANCER? AND OTHER QUESTIONS ANSWERED. | Positively aware : the monthly journal of the Test Positive Aware Network | 2015 |
| 26717411 | HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing. | PLoS One | 2015 |
| 26181707 | Brief Report: Cobicistat Compared With Ritonavir as a Pharmacoenhancer for Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate: Week 144 Results. | Journal of acquired immune deficiency syndromes (1999) | 2015 |
| 26600459 | A Randomized Trial of Time-Limited Antiretroviral Therapy in Acute/Early HIV Infection. | PLoS One | 2015 |
| 26302604 | START NOW. A NEW STUDY CONFIRMS THAT EVERYONE WHO IS HIV-POSITIVE SHOULD BE ON TREATMENT. | Positively aware : the monthly journal of the Test Positive Aware Network | 2015 |
| 26302594 | ANTIRETROVIRAL THERAPY IN 2015. ONE DOCTOR'S PERSPECTIVE ON THE STATE OF HIV TREATMENT. | Positively aware : the monthly journal of the Test Positive Aware Network | 2015 |
| 26423382 | HIV Infection: Still a Disease for Experts. | Clinical Infectious Diseases | 2015 |
| 26693493 | Get Rich Quick With Old Generic Drugs! The Pyrimethamine Pricing Scandal. | Open Forum Infectious Diseases | 2015 |
| 24602844 | Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. | Lancet Infect Dis | 2014 |
| 25287588 | Rationale and evidence for human immunodeficiency virus treatment as prevention at the individual and population levels. | Infectious Disease Clinics of North America | 2014 |
| 25397511 | Long-term efficacy and safety of E/C/F/TDF vs EFV/FTC/TDF and ATV+RTV+FTC/TDF in HIV-1-infected treatment-naïve subjects ⿥50 years. | Journal of the International AIDS Society | 2014 |
| 25734132 | Fatal Granulomatous Amebic Encephalitis Due to Balamuthia mandrillaris in New Mexico: A Case Report. | Open Forum Infectious Diseases | 2014 |
| 25433663 | Discontinuation of tenofovir disoproxil fumarate for presumed renal adverse events in treatment-naïve HIV-1 patients: meta-analysis of randomized clinical studies. | HIV Clinical Trials | 2014 |
| 24457345 | Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. | Clin Infect Dis | 2014 |
| 24256630 | A randomized, double-blind comparison of single-tablet regimen elvitegravir/cobicistat/emtricitabine/tenofovir DF versus single-tablet regimen efavirenz/emtricitabine/tenofovir DF for initial treatment of HIV-1 infection: analysis of week 144 results. | J Acquir Immune Defic Syndr | 2014 |
| 24343580 | Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. | Clin Infect Dis | 2014 |
| 24235263 | Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America. | Clin Infect Dis | 2014 |
| 25038359 | Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel. | JAMA | 2014 |
| 25032989 | Hepatitis C virus testing in adults living with HIV: a need for improved screening efforts. | PLoS One | 2014 |